Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy
Medicinal Research Reviews · 2025-05 · 45 (3) · 867-886
DOI: 10.1002/med.22093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 17.12.2024. Verfasst von Yingjun Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sunshine Lake Pharma Co. Ltd., Dongguan, China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Radioisotopes, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 157 Literaturangaben. Gefördert von: This research was supported by Sunshine Lake Pharma Co. Ltd..
Abstract (Originalsprache)
Targeted charged alpha‐ and beta‐particle therapies are currently being used in clinical radiation treatments as newly developed methods for either killing or controlling tumor cell growth. The alpha particles can be generated either through a nuclear decay reaction or in situ by a nuclear fission reaction such as the boron neutron capture reaction. Different strategies have been employed to improve the selectivity and delivery of radiation dose to tumor cells based on the source of the clinically used alpha particles. As a result, the side effects of the treatment can be minimized. The increasing attention and research efforts on targeted alpha‐particle therapy have been fueled by exciting results of both academic research and clinical trials. It is highly anticipated that alpha‐particle therapy will improve the efficacy of treating malignant tumors. In this overview, we compare radionuclide drug conjugates (RDC) with boron neutron capture therapy (BNCT) to present recent developments in targeted alpha‐particle therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sunshine Lake Pharma Co. Ltd., Dongguan, China.
- Laboratory for Drug Discovery from Natural Resources & Industrialization, School of Pharmacy, Macau University of Science and Technology, Macau, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
- Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
ORCID-Profile: Yinghuai Zhu
Förderung
- This research was supported by Sunshine Lake Pharma Co. Ltd.
Zitieren
APA
Zhang, Y., Coghi, P., Ren, Z., Hosmane, N. S., & Zhu, Y. (2025). Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy. Medicinal Research Reviews, 45(3), 867-886. https://doi.org/10.1002/med.22093
Vancouver
Zhang Y, Coghi P, Ren Z, Hosmane NS, Zhu Y. Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy. Medicinal Research Reviews. 2025;45(3):867-886. doi:10.1002/med.22093
BibTeX
@article{Zhang2025,
author = {Zhang, Yingjun and Coghi, Paolo and Ren, Zimo and Hosmane, Narayan S and Zhu, Yinghuai},
title = {Comparison of Radionuclide Drug Conjugates With Boron Neutron Capture Therapy: An Overview of Targeted Charged Particle Radiation Therapy},
journal = {Medicinal Research Reviews},
year = {2025},
volume = {45},
number = {3},
pages = {867--886},
doi = {10.1002/med.22093}
}
EUVIMED